Table of Content
Introduction
Genital Herpes - Overview
Genital Herpes - Therapeutics Development
Genital Herpes - Therapeutics Assessment
Genital Herpes - Companies Involved in Therapeutics Development
Genital Herpes - Drug Profiles
Genital Herpes - Dormant Projects
Genital Herpes - Discontinued Products
Genital Herpes - Product Development Milestones
Appendix
List of Figures
Number of Products under Development for Genital Herpes, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Targets, H1 2020
Number of Products by Stage and Targets, H1 2020
Number of Products by Mechanism of Actions, H1 2020
Number of Products by Stage and Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020
List of Tables
Number of Products under Development for Genital Herpes, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Genital Herpes - Pipeline by Abivax SA, H1 2020
Genital Herpes - Pipeline by Admedus Ltd, H1 2020
Genital Herpes - Pipeline by AiCuris GmbH & Co KG, H1 2020
Genital Herpes - Pipeline by Astellas Pharma Inc, H1 2020
Genital Herpes - Pipeline by Auritec Pharmaceuticals Inc, H1 2020
Genital Herpes - Dormant Projects, H1 2020
Genital Herpes - Dormant Projects, H1 2020 (Contd..1), H1 2020
Genital Herpes - Dormant Projects, H1 2020 (Contd..2), H1 2020
Genital Herpes - Discontinued Products, H1 2020